BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6426781)

  • 1. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ; Ryoyama K; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F; Pavelic Z; Mihich E
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of the cell-mediated cytotoxic response induced in mixed cell culture by adriamycin.
    Arinaga S; Akiyoshi T; Tsuji H
    Jpn J Cancer Res; 1985 May; 76(5):414-9. PubMed ID: 3159614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of cytolytic T lymphocytes in vitro. XI. Accessory cell requirement in secondary responses to particulate alloantigen.
    Degiovanni G; Cerottini JC; Brunner KT
    Eur J Immunol; 1980 Jan; 10(1):40-5. PubMed ID: 6153984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
    Mace K; Mayhew E; Mihich E; Ehrke MJ
    Cancer Res; 1988 Jan; 48(1):130-6. PubMed ID: 3257160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.
    Ehrke MJ; Maccubbin D; Ryoyama K; Cohen SA; Mihich E
    Cancer Res; 1986 Jan; 46(1):54-60. PubMed ID: 3484381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW; Mokyr MB
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory cell requirements for the generation of cytolytic T lymphocytes.
    Lutz CT; Fitch FW
    J Immunol; 1979 Jun; 122(6):2598-604. PubMed ID: 109533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lectin-induced cellular cytotoxicity mediated by mouse spleen cells and the role of lymphotoxin.
    Sawada J; Osawa T
    Immunology; 1980 Nov; 41(3):525-34. PubMed ID: 6970163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-associated macrophage precursor activity: isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1986 Feb; 136(3):837-43. PubMed ID: 3079800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in cell-mediated immune functions induced in mouse splenic lymphocytes by polycyclic aromatic hydrocarbons.
    Wojdani A; Alfred LJ
    Cancer Res; 1984 Mar; 44(3):942-5. PubMed ID: 6420057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of adherent/phagocytic cells for the induction of F1 anti-parent cell-mediated lympholysis. I. Parental adherent splenocytes serve as stimulators.
    Freimuth WW; Cudkowicz G
    J Immunol; 1981 Oct; 127(4):1504-9. PubMed ID: 7024408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients.
    Arinaga S; Akiyoshi T; Tsuji H
    Cancer Res; 1986 Aug; 46(8):4213-6. PubMed ID: 3488123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.